Enterprise Value
4.09M
Cash
315.4M
Avg Qtr Burn
-14.23M
Short % of Float
22.24%
Insider Ownership
36.97%
Institutional Own.
73.68%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DT-216 Details Friedreich’s Ataxia | Phase 1 Data readout |